Optic nerve injuries resulting from optic neuropathies, traumas, or tumors are characterized by optic nerve degeneration, resulting in partial to complete loss of vision. These injuries specifically affect the retinal ganglion cells (RGCs), whose axons form the optic nerve, and their cell bodies degenerate as a consequence of the injury.
Cell therapy in most patients with optic nerve atrophy showed good improvement in visual acuity, visual field, light sensitivity, night vision, strabismus, and nystagmus.
Moreover, Cell therapy treatment had resulted in significantly slowing down further vision loss in patients with progressive conditions.
